Skip to main content

Table 2 Adjusted risks of outcomes associated with the hepatitis coinfection*

From: Hepatotoxicity and effectiveness of a Nevirapine-based antiretroviral therapy in HIV-infected patients with or without viral hepatitis B or C infection in Cameroon

Outcome Ratio or coefficient 95% confidence interval p
Hepatotoxicity    
   Grade ≥2 2.94 1.49-5.81 0.002
   Grade ≥3 2.18 0.61-7.75 0.2
   Highest grade 1.83 1.28-2.60 0.001
CD4 cell count increase||    
   Primary slope 0.02 -0.20 to 0.24 0.9
   Secondary slope -0.04 -0.38 to 0.31 0.8
   Quadratic effect 0.00 -0.00 to 0.01 0.8
Viral load < 400 copies/mL 1.00 0.68-1.47 0.9
Death 0.52 0.14-1.93 0.3
Death or new AIDS-defining event 0.37 0.11-1.29 0.1
  1. * Coinfected patients versus monoinfected patients. Cox regression. Poisson regression. || Mixed-effect linear regression of the square root-transformed CD4 cell count. From 6 months to 24 months, combined with the primary slope.